Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. AMC
4. MSFT
5. ACN
6. FFAI
7. PAGP
8. WBD
9. FAN
10. COHR

Go back to Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
(NASDAQ: DNTH) Delayed: 96.81 --0 (-0%)
Previous Close $96.81    52 Week High $ 
Open $96.81    52 Week Low $ 
Day High $96.81    P/E N/A 
Day Low $96.81    EPS $ 
Volume 1,241